{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:24:45Z","timestamp":1740169485299,"version":"3.37.3"},"reference-count":22,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T00:00:00Z","timestamp":1550361600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"funder":[{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","award":["HD087101","LSM-800"],"award-info":[{"award-number":["HD087101","LSM-800"]}],"id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"UCLA-Caltech Medical Scientist Training Program","doi-asserted-by":"publisher","award":["T32GM008042"],"award-info":[{"award-number":["T32GM008042"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000073","name":"Autism Speaks","doi-asserted-by":"publisher","award":["9172"],"award-info":[{"award-number":["9172"]}],"id":[{"id":"10.13039\/100000073","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000124","JAM-A"],"award-info":[{"award-number":["UL1TR000124","JAM-A"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["P50-HD-055784","JAMA"],"award-info":[{"award-number":["P50-HD-055784","JAMA"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000912","name":"March of Dimes","doi-asserted-by":"publisher","award":["6-FY12-324","JAM-A"],"award-info":[{"award-number":["6-FY12-324","JAM-A"]}],"id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MIRNA"],"published-print":{"date-parts":[[2019,2,17]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>We have previously described mosaic mutations in the RNase IIIb domain\nof DICER1that display global developmental delays, lung cysts, somatic overgrowth, macrocephaly\nand Wilms tumor. This constellation of phenotypes was classified as GLOW syndrome. Due to the\nphenotypic overlap between GLOW and syndromes caused by mutations in the PI3K\/AKT\/mTOR\npathway, we hypothesized that alterations in miRNA regulation of this pathway cause its specific\nconstellation of phenotypes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>To test the hypothesis that DICER1 \u201chot spot\u201d mutations associated with GLOW syndrome\nactivate PI3K\/AKT\/mTOR signaling.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title> Methods:<\/jats:title>\n<jats:p>We developed HEK293T cells with loss of exon 25 in DICER1, a genetic modification that\nis synonymous with the \u201chot spot\u201d RNAseIIIb mutations that cause GLOW syndrome. We assayed\nthe cells for activation of the PI3K\/AKT\/mTOR signaling pathway.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title> Results:<\/jats:title>\n<jats:p>We observed activation of the PI3K\/AKT\/mTOR pathway as demonstrated by increased\npS6Kinase, p4EBP1 and pTSC2 levels. Additionally, these cells demonstrate a striking cellular phenotype,\nwith the ability to form spheres when the serum is removed from their growth medium. The\ncells in these spheres are Oct4 and Sox2 positive and exhibit the property of reversion with the addition\nof serum. We queried miRNA expression data and identified a population of miRNAs that increase\ndue to these mutations and target negative regulators of the PI3K\/AKT\/mTOR pathway.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>This work identifies the delicate and essential role for miRNA control of the\nPI3K\/AKT\/mTOR pathway. We conclude that the phenotypes observed in the GLOW syndrome are\nthe result of PI3K\/AKT\/mTOR activation.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2211536608666190624114424","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T08:01:18Z","timestamp":1581926478000},"page":"70-80","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hotspot Mutations in DICER1 Causing GLOW Syndrome-Associated Macrocephaly via Modulation of Specific microRNA Populations Result in the Activation of PI3K\/ATK\/mTOR Signaling"],"prefix":"10.2174","volume":"9","author":[{"given":"Steven D.","family":"Klein","sequence":"first","affiliation":[{"name":"Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, California, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian A.","family":"Martinez-Agosto","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, California, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/jmedgenet-2013-101943","volume":"51","author":"Klein S.","year":"2014","unstructured":"Klein S.; Lee H.; Ghahremani S.; Expanding the phenotype of mutations in DICER1: Mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome. J Med Genet 2014,51(5),294-302","journal-title":"J Med Genet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrc3802","volume":"14","author":"Foulkes W.D.","year":"2014","unstructured":"Foulkes W.D.; Priest J.R.; Duchaine T.F.; DICER1: Mutations, microRNAs and mechanisms. Nat Rev Cancer 2014,14(10),662-672","journal-title":"Nat Rev Cancer"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2015.09.002","volume":"31","author":"Desvignes T.","year":"2015","unstructured":"Desvignes T.; Batzel P.; Berezikov E.; miRNA nomenclature: A view incorporating genetic origins, biosynthetic pathways, and sequence variants. Trends Genet 2015,31(11),613-626","journal-title":"Trends Genet"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17050789","volume":"17","author":"Yan S.","year":"2016","unstructured":"Yan S.; Jiao K.; Functions of miRNAs during mammalian heart development. Int J Mol Sci 2016,17(5)","journal-title":"Int J Mol Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/pbc.24555","volume":"60","author":"Schiffman J.D.","year":"2013","unstructured":"Schiffman J.D.; Geller J.I.; Mundt E.; Means A.; Means L.; Means V.; Update on pediatric cancer predisposition syndromes. Pediatr Blood Cancer 2013,60(8),1247-1252","journal-title":"Pediatr Blood Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1126\/science.1174334","volume":"325","author":"Hill D.A.","year":"2009","unstructured":"Hill D.A.; Ivanovich J.; Priest J.R.; DICER1 mutations in familial pleuropulmonary blastoma. Science 2009,325(5943),965","journal-title":"Science"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.path.2016.01.002","volume":"9","author":"Stewart C.J.","year":"2016","unstructured":"Stewart C.J.; Charles A.; Foulkes W.D.; Gynecologic manifestations of the DICER1 syndrome. Surg Pathol Clin 2016,9(2),227-241","journal-title":"Surg Pathol Clin"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jpurol.2015.08.012","volume":"12","author":"Faure A.","year":"2016","unstructured":"Faure A.; Atkinson J.; Bouty A.; DICER1 pleuropulmonary blastoma familial tumour predisposition syndrome: What the paediatric urologist needs to know. J Pediatr Urol 2016,12(1),5-10","journal-title":"J Pediatr Urol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/jmg.2010.083790","volume":"48","author":"Slade I.","year":"2011","unstructured":"Slade I.; Bacchelli C.; Davies H.; DICER1 syndrome: Clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet 2011,48(4),273-278","journal-title":"J Med Genet"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/gim.2016.83","volume":"19","author":"Khan N.E.","year":"2017","unstructured":"Khan N.E.; Bauer A.J.; Doros L.; Macrocephaly associated with the DICER1 syndrome. Genet Med 2017,19(2),244-248","journal-title":"Genet Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/path.4135","volume":"229","author":"Anglesio M.S.","year":"2013","unstructured":"Anglesio M.S.; Wang Y.; Yang W.; Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage. J Pathol 2013,229(3),400-409","journal-title":"J Pathol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/path.4196","volume":"230","author":"Wu M.K.","year":"2013","unstructured":"Wu M.K.; Sabbaghian N.; Xu B.; Biallelic DICER1 mutations occur in Wilms tumours. J Pathol 2013,230(2),154-164","journal-title":"J Pathol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"Ran F.A.","year":"2013","unstructured":"Ran F.A.; Hsu P.D.; Wright J.; Agarwala V.; Scott D.A.; Zhang F.; Genome engineering using the CRISPR-Cas9 system. Nat Protoc 2013,8(11),2281-2308","journal-title":"Nat Protoc"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"Doench J.G.","year":"2016","unstructured":"Doench J.G.; Fusi N.; Sullender M.; Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol 2016,34(2),184-191","journal-title":"Nat Biotechnol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"Hsu P.D.","year":"2013","unstructured":"Hsu P.D.; Scott D.A.; Weinstein J.A.; DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 2013,31(9),827-832","journal-title":"Nat Biotechnol"},{"key":"ref=16","author":"Doros L.","year":"1993","unstructured":"Doros L.; Schultz K.A.; Stewart D.R.; Bauer A.J.; Williams G.; Rossi C.T.;  Gene Reviews(R) Seattle 1993","journal-title":"Gene Reviews(R) Seattle"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.tibs.2008.09.002","volume":"33","author":"Aberdam D.","year":"2008","unstructured":"Aberdam D.; Candi E.; Knight R.A.; Melino G.; miRNAs, \u2018stemness\u2019 and skin. Trends Biochem Sci 2008,33(12),583-591","journal-title":"Trends Biochem Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.stemcr.2014.05.013","volume":"3","author":"Shukrun R.","year":"2014","unstructured":"Shukrun R.; Pode-Shakked N.; Pleniceanu O.; Wilms\u2019 tumor blastemal stem cells dedifferentiate to propagate the tumor bulk. Stem Cell Reports 2014,3(1),24-33","journal-title":"Stem Cell Reports"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/(SICI)10968628(19981002)79:4<268:AID-AJMG7>3.0.CO;2-I","volume":"79","author":"Beckwith J.B.","year":"1998","unstructured":"Beckwith J.B.; Nephrogenic rests and the pathogenesis of Wilms tumor: Developmental and clinical considerations. Am J Med Genet 1998,79(4),268-273","journal-title":"Am J Med Genet"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/PAS.0b013e3181484165","volume":"32","author":"Hill D.A.","year":"2008","unstructured":"Hill D.A.; Jarzembowski J.A.; Priest J.R.; Williams G.; Schoettler P.; Dehner L.P.; Type I pleuropulmonary blastoma: Pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol 2008,32(2),282-295","journal-title":"Am J Surg Pathol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.leukres.2007.02.020","volume":"31","author":"Rohner A.","year":"2007","unstructured":"Rohner A.; Langenkamp U.; Siegler U.; Kalberer C.P.; Wodnar-Filipowicz A.; Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. Leuk Res 2007,31(10),1393-1402","journal-title":"Leuk Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0190-9622(87)80249-9","volume":"16","author":"Happle R.","year":"1987","unstructured":"Happle R.; Lethal genes surviving by mosaicism: A possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol 1987,16(4),899-906","journal-title":"J Am Acad Dermatol"}],"container-title":["MicroRNA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/172948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T06:56:16Z","timestamp":1583996176000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/172948\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,17]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2,17]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2211536608666190624114424","relation":{},"ISSN":["2211-5366"],"issn-type":[{"type":"print","value":"2211-5366"}],"subject":[],"published":{"date-parts":[[2019,2,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-01-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}